<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  [See Medication Guide (17.6)]<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     <BR>                        17.1 Benefits and Risks <BR>                     <BR>                     <BR>                        <BR>                           Summarize the effectiveness features and potential side effects of clopidogrel. <BR>                           Tell patients to take clopidogrel exactly as prescribed. <BR>                           Remind patients not to discontinue clopidogrel without first discussing it with the physician who prescribed clopidogrel. <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     <BR>                        17.2 Bleeding <BR>                     <BR>                     <BR>                        Inform patients that they: <BR>                        <BR>                           will bruise and bleed more easily. <BR>                           will take longer than usual to stop bleeding. <BR>                           should report any unanticipated, prolonged, or excessive bleeding, or blood in their stool or urine.  <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     <BR>                        17.3 Other Signs and Symptoms Requiring Medical Attention <BR>                     <BR>                     <BR>                        <BR>                           Inform patients that TTP is a rare but serious condition that has been reported with clopidogrel and other drugs in this class of drugs. <BR>                           Instruct patients to get prompt medical attention if they experience any of the following symptoms that cannot otherwise be explained: fever, weakness, extreme skin paleness, purple skin patches, yellowing of the skin or eyes, or neurological changes. <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     <BR>                        17.4 Invasive Procedures <BR>                     <BR>                     <BR>                        Instruct patients to: <BR>                        <BR>                           inform physicians and dentists that they are taking clopidogrel before any invasive procedure is scheduled. <BR>                           tell the doctor performing the invasive procedure to talk to the prescribing health care professional before stopping clopidogrel. <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     <BR>                        17.5 Concomitant Medications <BR>                     <BR>                     <BR>                        Ask patients to list all prescription medications, over-the-counter medications, or dietary supplements they are taking or plan to take, including prescription or over-the-counter proton pump inhibitors (e.g., omeprazole), warfarin, or NSAIDs [see <BR>                              Warnings and Precautions (5)<BR>                           ].  <BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>